Solubilizing poorly soluble antimycotic agents by emulsification via a solvent-free process

AAPS PharmSciTech

Volumn 5, Issue 1, 2004, Pages

  Akkar, Aslihan ^a   Namsolleck, Pawel ^b   Blaut, Michael ^b   Müller, Rainer H ^c  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c PharmaSol GmbH   (Germany)

Author keywords

High pressure homogenization; Itraconazole; Ketoconazole; Nanoemulsions; Stability

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CARBAMAZEPINE; ITRACONAZOLE; KETOCONAZOLE; LIPOFUNDIN; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; PHOSPHATIDYLCHOLINE; POLYSORBATE 80; SOLVENT; STABILIZING AGENT; WATER OIL CREAM; OIL; WATER;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISPERSION; DRUG DETERMINATION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; EMULSION; HYBRID; LOAD CARRYING CAPACITY; PROCESS TECHNOLOGY; SOLUBILIZATION; CHEMISTRY; SOLUBILITY;

ANTIFUNGAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; EMULSIONS; ITRACONAZOLE; KETOCONAZOLE; OILS; SOLUBILITY; SOLVENTS; WATER;

EID: 23144442213     PISSN: 15309932     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Nyström C. Dissolution properties of poorly soluble drugs: Theoretical background and possibilities to improve the dissolution behaviour. In: Benita S, Müller RH, Böhm BHL, eds. Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs. Stuttgart, Germany: Medpharm Scientific Publishers; 1998:143.
2. Thompson DO. Solubilizing Difficult Compounds, Give Them a Chance. In: 7th Annual Drug Delivery Partnerships Conference/Institute for International Research (IIR), Vol B4 (Workshop 1); January 28-30, 2003; San Diego, CA.
3. Jung YJ, Yoo SD, Lee SH, Kim KH, Yoon SD, Lee KH. Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. Int J Pharm. 1999;187:209-218.
4. Frömming KH. Cyclodextrine - eine vielseitig verwendbare Gruppe neuer Hilfsstoffe. In: Müller RH, Hildebrand GE, eds. Pharmazeutische Technologie: Moderne Arzneiformen. Stuttgart, Germany: Wissenschaftliche Verlag GmbH; 1998:13-17.
5. Schmitt J. Parenterale Fettemulsionen als Arzneistoffträger. In:Müller RH, Hildebrand GE, eds. Pharmazeutische Technologie: Moderne Arzneiformen. Stuttgart, Germany: Wissenschaftliche Verlag GmbH; 1998:137.
6. Kirsh R, Goldstein R, Tarloff J, Parris D, Hook J, Hanna N. An emulsion formulation of Amphotericin B improves the therapeutic index when treating systemic murine candidiasis. J Infect Dis. 1988;158:1065-1070.
7. Caillot D, Casasnovas O, Solary E, Chavanet P, Bonnotte B, Reny G. Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients. J Antimicrob Chemother. 1993;31:161-169.
8. Shadkhan Y, Segal E, Bor A, Gov Y, Rubin M, Lichtenberg D. The use of commercially available lipid emulsions for the preparation of Amphotericin B-lipid admixtures. J Antimicrob Chemother. 1997;39:655-658.
9. Davis SS, Washington C. Drug emulsion. European Patent ZA8804513. March 29, 1989.
10. Müller RH. Dispersions for the formulation of slightly or poorly soluble agents, DE 100 36 871.9, (2000), PCT application PCT/EP01/08726. 2001.
11. Müller RH, Schuhmann R. Teilchengrößenmessung in der Labor-praxis. Stuttgart, Germany: Wissenschaftliche Verlag GmbH; 1997;38:65-66.
12. Müller RH. Zetapotential und Partikelladung in der Laborpraxis. Stuttgart, Germany. Wissenschaftliche Verlag GmbH; 1996;37:179.
13. Müller RH, Heinemann S. Fat emulsions for parenteral nutrition. I. Evaluation of microscopic and laser light scattering methods for the determination of the physical stability. Clin Nutr. 1992;11:223-236.
14. Akkar A, Müller RH. Formulation of i.v. carbamazepine emulsions by SolEmuls Technology. Eur J Pharm Biopharm. 2003;55:305-312.
15. Martindale. 30th ed. London, UK: Pharmaceutical Press; 1993: 326.
16. Müller RH, Böhm BHL. Nanosuspensions. In: Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs. Müller RH, Benita S, Böhm BHL, eds. Stuttgart, Germany: Medpharm Scientific Publishers; 1998:153.
17. Schuhmann R. Physikalische Stabilität Parenterale Fettemulsionen, entwicklung eines Untersuchungschemas Unter Besonderem Aspekt Analytischer Möglichkeiten, in Department of Pharmaceutical Technology, Biotechnology and Quality Management. Berlin, Germany: Free University of Berlin; 1995.
18. Akkar A, Müller RH. Drug nanocrystals produced by high pressure homogenization. In: "Access of Therapeutics to the Brain" 8th UKICRS Symposium. Poster No.12. January 10, 2003. Belfast, Ireland.
19. Müller RH, Schmidt S. SolEmuls technology for i.v. emulsions of poorly soluble drugs: Amphotericin B. in 4th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology. April 8-11, 2002. Florence, Italy.